Follow
Gene and Cell Therapy
With the goal of treating and curing disease, gene and cell therapy provide treatment by means of altering a person's genetic code and transferring live cells to improve symptoms and reduce levels of disease-causing proteins.
-
JUN 03, 2021 | 8:00 AM
Date: June 3, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Molecular combing provides unbiased quantification and characterization of DNA structure and dynamics by imaging single DN...JUN 03, 2021 | 12:00 PM
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...Speaker: Premkumar Jayaraman, PhD , Emily Benz , Eric DubofskySponsored By: Thermo Fisher ScientificJUN 02, 2021 | 12:00 PM
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy (CART19) occurs in 10% to 20% of patients with acute lymphoblastic leukemia (ALL); however, the mechanisms of thi...Speaker: Yong Gu Lee Ph.DJUN 02, 2021 | 12:00 AM
Learning Objectives: 1. Define “universal CARs” and describe their mechanism of action. 2. Explain current challenges in CAR T cell therapy. 3. Describe potential benefits and ch...JUN 02, 2021 | 12:00 AM
Prostate cancers are considered immunologically ‘cold’ tumors given the very few patients who respond to checkpoint inhibitor therapy (CPI). Recently, enrichment of interferon st...JUN 02, 2021 | 12:00 AM
Rhabdomyosarcoma (RMS) is a soft tissue cancer commonly arising in muscle and is the most common soft tissue cancer in children. Patients with metastatic RMS have a poor prognosis that has n...MAY 27, 2021 | 8:00 AM
Date: May 27, 2021 Time: 8:00am (PDT), 11:00am (EDT) With social distancing measures still enforced in large parts of the world, many researchers must minimize time in the lab where they may...MAY 25, 2021 | 8:00 AM
Date: May 25, 2021 Time: 8:00am (PDT) Reliable expression of recombinant proteins in human, CHO, or insect cells is essential for many aspects of biomedical research and drug development, bu...MAY 11, 2021 | 10:00 AM
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...Speaker: Paulina Kocjan , Kate Meola , Zareh ZurabyanAPR 29, 2021 | 3:00 PM
...APR 21, 2021 | 12:00 AM
Engineered cell therapy is an emerging field of science to target and treat cancer. Current strategies include utilizing immune cells such as T cells, NK cells and Macrophages or other cells...APR 20, 2021 | 4:30 PM
Interest in cell and gene therapy-based disease prevention and treatment has increased rapidly over the last few decades, however there are still many hurdles to overcome and further progres...Speaker: Andrea O'Hara, PhDAPR 08, 2021 | 2:15 PM
The adeno-associated virus (AAV) has evolved overlapping genes to maximize its genome use, as with the recently-discovered ORF in the cap gene which encodes a membrane-associated accessory p...Speaker: Lionel Galibert, Ph.D.APR 08, 2021 | 1:00 PM
Advanced therapy medicinal products (ATMPs) are ‘living drugs’ that have proven highly effective at treating diseases, such as cancer, that were once thought untreatable. As &lsq...Speaker: Brian J. Hawkins, Ph.D.APR 08, 2021 | 10:00 AM
Cell therapies, including chimeric antigen receptor (CAR) T-cell therapy, are emerging as promising treatments, especially for hematological malignancies. However, many challenges remain in...Speaker: Adriana Suarez, Ph.D.APR 07, 2021 | 12:00 PM
Recombinant adeno-associated virus (AAV) and lentiviral vectors (LV) are vehicles for direct delivery of therapeutic genes to patients' cells. In the coming years, the use of AAV and LV...Speaker: Sandy Tseng, PhDAPR 07, 2021 | 1:00 PM
In this fireside chat, we’ll discuss how gene editing protocols can benefit from long-read sequencing at various stages to optimize and enhance vector integrity, which cannot be addres...Speaker: Elizabeth Louie, Ph.D.APR 07, 2021 | 10:00 AM
Synthetic adeno-associated virus (AAV) biology is an emerging interdisciplinary field that involves the re-design of all AAV components, including capsids, packaged genomes, and starting mat...Speaker: Jude Samulski, Ph.D.APR 07, 2021 | 12:00 AM
Potency is a critical quality attribute of biological products, defined by the US FDA as the specific ability of the product to cause the required therapeutically clinical benefit. Potency a...MAR 31, 2021 | 8:00 AM
Date: March 31, 2021 Time: 08:00am PST CytoFLEX SRT has enabled researcher lead self-service sorting. The need for a cell sorting expert to setup and maintain the sorter status is now necess...MAR 30, 2021 | 8:00 AM
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...Speaker: Mary Ann Santos , Emily Benz , Eric DubofskySponsored By: Thermo Fisher Scientific/GibcoMAR 17, 2021 | 8:00 AM
Date: March 17, 2021 Time: 08:00am (PST) Research focused on SARS-CoV-2 has become a primary focus in genomic and molecular biology fields. With a constantly changing field with new methods...MAR 11, 2021 | 8:00 AM
Date: March 11, 2021 Time: 8:00am (PST), 11:00am (EST) g the toxicity profile of a compound is a necessity across industries and the various stages of drug development. Early stage mechanism...FEB 24, 2021 | 10:00 AM
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
JUN 03, 2021 | 8:00 AM
Date: June 3, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Molecular combing provides unbiased quantification and characterization of DNA structure and dynamics by imaging single DN...
JUN 03, 2021 | 12:00 PM
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
Speaker:
Premkumar Jayaraman, PhD
, Emily Benz
, Eric Dubofsky
Sponsored By: Thermo Fisher Scientific
JUN 02, 2021 | 12:00 PM
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy (CART19) occurs in 10% to 20% of patients with acute lymphoblastic leukemia (ALL); however, the mechanisms of thi...
Speaker:
Yong Gu Lee Ph.D
JUN 02, 2021 | 12:00 AM
Learning Objectives: 1. Define “universal CARs” and describe their mechanism of action. 2. Explain current challenges in CAR T cell therapy. 3. Describe potential benefits and ch...
JUN 02, 2021 | 12:00 AM
Prostate cancers are considered immunologically ‘cold’ tumors given the very few patients who respond to checkpoint inhibitor therapy (CPI). Recently, enrichment of interferon st...
JUN 02, 2021 | 12:00 AM
Rhabdomyosarcoma (RMS) is a soft tissue cancer commonly arising in muscle and is the most common soft tissue cancer in children. Patients with metastatic RMS have a poor prognosis that has n...
MAY 27, 2021 | 8:00 AM
Date: May 27, 2021 Time: 8:00am (PDT), 11:00am (EDT) With social distancing measures still enforced in large parts of the world, many researchers must minimize time in the lab where they may...
MAY 25, 2021 | 8:00 AM
Date: May 25, 2021 Time: 8:00am (PDT) Reliable expression of recombinant proteins in human, CHO, or insect cells is essential for many aspects of biomedical research and drug development, bu...
MAY 11, 2021 | 10:00 AM
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
Speaker:
Paulina Kocjan
, Kate Meola
, Zareh Zurabyan
APR 29, 2021 | 3:00 PM
...
APR 21, 2021 | 12:00 AM
Engineered cell therapy is an emerging field of science to target and treat cancer. Current strategies include utilizing immune cells such as T cells, NK cells and Macrophages or other cells...
APR 20, 2021 | 4:30 PM
Interest in cell and gene therapy-based disease prevention and treatment has increased rapidly over the last few decades, however there are still many hurdles to overcome and further progres...
Speaker:
Andrea O'Hara, PhD
APR 08, 2021 | 2:15 PM
The adeno-associated virus (AAV) has evolved overlapping genes to maximize its genome use, as with the recently-discovered ORF in the cap gene which encodes a membrane-associated accessory p...
Speaker:
Lionel Galibert, Ph.D.
APR 08, 2021 | 1:00 PM
Advanced therapy medicinal products (ATMPs) are ‘living drugs’ that have proven highly effective at treating diseases, such as cancer, that were once thought untreatable. As &lsq...
Speaker:
Brian J. Hawkins, Ph.D.
APR 08, 2021 | 10:00 AM
Cell therapies, including chimeric antigen receptor (CAR) T-cell therapy, are emerging as promising treatments, especially for hematological malignancies. However, many challenges remain in...
Speaker:
Adriana Suarez, Ph.D.
APR 07, 2021 | 12:00 PM
Recombinant adeno-associated virus (AAV) and lentiviral vectors (LV) are vehicles for direct delivery of therapeutic genes to patients' cells. In the coming years, the use of AAV and LV...
Speaker:
Sandy Tseng, PhD
APR 07, 2021 | 1:00 PM
In this fireside chat, we’ll discuss how gene editing protocols can benefit from long-read sequencing at various stages to optimize and enhance vector integrity, which cannot be addres...
Speaker:
Elizabeth Louie, Ph.D.
APR 07, 2021 | 10:00 AM
Synthetic adeno-associated virus (AAV) biology is an emerging interdisciplinary field that involves the re-design of all AAV components, including capsids, packaged genomes, and starting mat...
Speaker:
Jude Samulski, Ph.D.
APR 07, 2021 | 12:00 AM
Potency is a critical quality attribute of biological products, defined by the US FDA as the specific ability of the product to cause the required therapeutically clinical benefit. Potency a...
MAR 31, 2021 | 8:00 AM
Date: March 31, 2021 Time: 08:00am PST CytoFLEX SRT has enabled researcher lead self-service sorting. The need for a cell sorting expert to setup and maintain the sorter status is now necess...
MAR 30, 2021 | 8:00 AM
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
Speaker:
Mary Ann Santos
, Emily Benz
, Eric Dubofsky
Sponsored By: Thermo Fisher Scientific/Gibco
MAR 17, 2021 | 8:00 AM
Date: March 17, 2021 Time: 08:00am (PST) Research focused on SARS-CoV-2 has become a primary focus in genomic and molecular biology fields. With a constantly changing field with new methods...
MAR 11, 2021 | 8:00 AM
Date: March 11, 2021 Time: 8:00am (PST), 11:00am (EST) g the toxicity profile of a compound is a necessity across industries and the various stages of drug development. Early stage mechanism...
FEB 24, 2021 | 10:00 AM
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...